Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04221529
Title Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide (SPACE)
Acronym SPACE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AIO-Studien-gGmbH
Age Groups: adult | senior
Covered Countries DEU | AUT

No variant requirements are available.